RxDoctor Payments Data

Stephen Bridgers, MD

Family Medicine · Clarkton, NCNPI 1922197136

Payments from drug & device makers

$791in general payments, 2019–2025

Across 53 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$359
  • Sanofi-aventis U.S. LLC$54
  • Amarin Pharma, Inc.$52
  • Merck$49
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • Amgen$40
  • plus $191 from 8 others

What the payments were for

  • Food & beverage$791100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$791 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$2,147
Medicare patients
29
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban122$90,442
OzempicSemaglutide73$75,584
JardianceEmpagliflozin75$60,327
JanuviaSitagliptin Phosphate36$36,054
TrulicityDulaglutide32$32,298
EntrestoSacubitril/Valsartan35$24,220
LinzessLinaclotide28$18,548
XareltoRivaroxaban29$18,496
MounjaroTirzepatide16$18,201
MyrbetriqMirabegron21$13,436
Repatha SureclickEvolocumab24$12,664
TradjentaLinagliptin25$12,391
Victoza 3-PakLiraglutide13$10,048
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen180$8,654
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,816

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$90,442122 claims
Novo NordiskOzempic$359$75,58473 claims
Boehringer IngelheimJardiance, Tradjenta$16$72,718100 claims
MerckJanuvia$49$36,05436 claims
AbbVieLinzess, Synthroid$40$23,597114 claims
Johnson & JohnsonXarelto$36$18,49629 claims
Sanofi-aventis U.S. LLCLantus$54$1,55025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Clarkton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →